This week, we continue our series of Homerun Slides from Dr. Stanley Schwartz focusing on the obesity epidemic. This week’s topics include: Gene Variants and Binge Eating as Predictors of Co-morbidities and Outcome of Treatment in Severe Obesity, Health Benefits of Modest Weight Loss, and a graphic representation of the …
Read More »2013 Obesity Epidemic, Part 2
In this second set of Homerun Slides from Dr. Stan Schwartz, we look at some of the popular perspectives on obesity in our modern society, including how Cultural Definitions Change Over Time, and how Thrifty Genes Contribute to Morbid Obesity….
Read More »2013 Obesity Epidemic, Part 1
In this week’s Homerun Slides, we begin a short series on the current status of the obesity epidemic, courtesy of Dr. Stanley Schwartz, FACP, FACE. Topics covered this week include the Epidemiology and Economics of Obesity/Diabetes in the U.S….
Read More »Probiotics Could Counter Obesity and Diabetes
Daily ingestion of the VSL#3 commercial probiotic product by mice led to an increase in GLP-1 levels which reduced appetite….
Read More »Can Home-based Childhood Obesity Prevention Programs Be Effective?
Taking into consideration the current global epidemic of childhood obesity….
Read More »Obesity and Being Overweight to Plateau by 2030
A new dynamic model capable of predicting overweight, obesity and extreme obesity trends shows….
Read More »Obesity and Hypertriglyceridemia Increase Risk for Diabetic Neuropathy
Obesity and hypertriglyceridemia are significant risk factors for diabetic neuropathy independent of glycemic control….
Read More »Bacteria in the Gut Improves the Management of Obesity and Type 2 Diabetes
The discovery of a gut bacteria could lead to new ways to control obesity and type 2 diabetes….
Read More »Leptin Gene Therapy Possible New Option in Treating Diabetes and Obesity
Leptin therapy studies are looking very promising for the treatment of diabetes in both type 1 and 2 patients….
Read More »Obesity without Health Problems: A New Inflammatory Marker Discovered
A marker called AIM (apoptosis inhibitor of macrophage) is an important factor in the autoimmune process. The inhibition of AIM may stop the body from producing antibodies which attack the self….
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.